Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Cancer Analytics Company Acquired in $1.9B Deal

The global pharmaceutical company Roche is purchasing the cancer data management and analytics enterprise Flatiron Health in New York for $1.9 billion. . . . → Read More: Cancer Analytics Company Acquired in $1.9B Deal

Report – Industry Pain, Addiction Drug Efforts Flagging

A report by a biotechnology industry organization says development efforts and financing for new drugs to treat pain and addiction are falling behind the health and safety needs of society. . . . → Read More: Report – Industry Pain, Addiction Drug Efforts Flagging

Neuro Therapy Company Spins-Off, Gains $20.8M Funding

A company developing treatments for cognitive impairment and Alzheimer’s disease is starting-up in Belgium, with a technology and financial backing from local and global businesses and investors. . . . → Read More: Neuro Therapy Company Spins-Off, Gains $20.8M Funding

Sanofi Buys Nano-Antibody Biotech in $4.8B Deal

Global drug maker Sanofi is acquiring a Belgian biotechnology company developing synthetic nanoscale therapeutic antibodies in a deal valued at $4.8 billion. . . . → Read More: Sanofi Buys Nano-Antibody Biotech in $4.8B Deal

T-Cell Therapy Company Gains $100M in Venture Funds

A 2 year-old company developing treatments for cancer and other diseases that activate or suppress the immune system with genetically engineered T-cells is raising $100 million in its first venture funding round. . . . → Read More: T-Cell Therapy Company Gains $100M in Venture Funds

Blood Disorder Drug Maker Acquired in $11.6B Deal

The global pharmaceutical company Sanofi is buying Bioverativ Inc., a developer of biologics to treat hemophilia and other rare blood disorders. . . . → Read More: Blood Disorder Drug Maker Acquired in $11.6B Deal

Medical Tech, Phone App Companies Partner on Wound Care

A company making wound care products is collaborating with a developer of mobile apps and analytics to design a more advanced diagnostics system for wounds. . . . → Read More: Medical Tech, Phone App Companies Partner on Wound Care

Celgene Acquires Cancer Drug Start-Up in $7B Deal

The biopharmaceutical company Celgene Corp. is acquiring Impact Biomedicines Inc., a developer of drugs to treat a type of blood-related cancer, in a deal valued as much as $7 billion. . . . → Read More: Celgene Acquires Cancer Drug Start-Up in $7B Deal

Biotech, Microsoft Partner on Immune System Diagnostics

A company that analyzes immune system genomics is collaborating with Microsoft Corporation to develop early-stage disease diagnostics. . . . → Read More: Biotech, Microsoft Partner on Immune System Diagnostics

RNA Therapies Start-Up Raises $55.3M in Early Funds

A start-up company creating treatments for inherited diseases that target faulty RNA transcribed from genetic codes is raising $55.3 million in its first venture funding round. . . . → Read More: RNA Therapies Start-Up Raises $55.3M in Early Funds